Study to Determine Presence of Prediabetes in Subjects with Cardiovascular Disease

Withdrawn

• Conditions: diabetes; increased blood sugar; 10082206; 10018424

• Registration Number: NL-OMON42994
• Lead Sponsor: Janssen-Cilag

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 70

Inclusion Criteria

* Man or woman of *18 years of age
* Documented symptomatic atherosclerotic CV disease including a history of one of the following:
* Stroke
* Myocardial infarction
* Hospitalized admission for unstable angina
* Percutaneous coronary intervention (with or without stenting)
* Peripheral revascularization (angioplasty or surgery)
JNJ-28431754
Clinical Protocol 28431754PRD0001
5
Approved, Date: 29 March 2016
* Symptomatic with documented hemodynamically significant carotid or peripheral vascular
disease

Exclusion Criteria

* History of T2DM, type 1 diabetes mellitus, latent autoimmune diabetes in adults (LADA), diabetic
ketoacidosis
* History of hereditary glucose-galactose malabsorption or primary renal glycosuria
* History of use of a glucose lowering drug (other than short-term use during a hospitalization or for
gestational diabetes; or subjects with a history of gestational diabetes may be included if at least
3 months has passed since the discontinuation of a glucose lowering drug)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>* support the assessment of the feasibility of conducting a clinical study in<br /><br>this population, and<br /><br>* identify subjects with CV disease and prediabetes who might have interest in<br /><br>participating in a future clinical study. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>/</p><br>